Company intelligence / Profile preview

Bradbury Asset Management

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Bradbury Asset Management is a Hong Kong-based asset management and financial services firm that specializes in international securities brokerage, asset management, investment funds, and wealth management.

Industry: Investors

Partnerships

Mirror Biologics (investment partnership)Crewstone Bradbury Penjana Fund (joint venture for technology/venture investment)IGC Pharma (investment in Phase 2 Alzheimer's program)

Beyond the preview

Go deeper on Bradbury Asset Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bradbury Asset Management.

Explore the full profile